Dr Jeffrey Sturchio
Dr. Jeffrey L. Sturchio is President and CEO at Rabin Martin, a global health strategy consulting firm, and former President and CEO of the Global Health Council. Before joining the Council in 2009, Dr. Sturchio was vice president of Corporate Responsibility at Merck & Co. Inc., president of The Merck Company Foundation and chairman of the U. S. Corporate Council on Africa (CCA), whose 180 member companies represent some 85 percent of total US private sector investment in Africa. While at Merck & Co., Inc., for more than a decade he was a leader of the company’s global HIV/AIDS policy and was centrally involved in the UN/Industry Accelerating Access Initiative established in 2000 to help improve HIV/AIDS care and treatment in the developing world. He was a member of the board of the African Comprehensive HIV/AIDS Partnerships in Botswana (2005-2009) and a member of the private sector delegation to the Board of the Global Fund to Fight AIDS, TB and Malaria (2002-2008).
He is chairman of the BroadReach Institute for Training and Education and a member of the boards of the U. S. Pharmacopeia, the Corporate Council on Africa, and the Museum of AIDS in Africa. Dr. Sturchio is also currently a visiting scholar at the Institute for Applied Economics, Global Health and the Study of Business Enterprise at The Johns Hopkins University; Senior Associate at the Center for Strategic and International Affairs; a principal of the Modernizing Foreign Assistance Network; Fellow of the American Association for the Advancement of Science; a member of the Council on Foreign Relations; and an advisor to amfAR, the Clinton Global Initiative and the NCD Alliance. He received an AB in history from Princeton University and a PhD in the history and sociology of science from the University of Pennsylvania. His publications include Noncommunicable diseases in the developing world: addressing global gaps in policy and research (edited with L. Galambos, Johns Hopkins University Press, 2013).